Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for braf protein, human (compound)
Most Correlated Studies
- Antitumor efficacy of GDC-0879 involving BRAF mutational status
- Melanoma cells Ras or BRAF mutant treated with sorafenib and/or diclofenac
- Response to TNF-alpha in melanoma cell lines with different mutations
- Gene expression in response to chemotherapy in human-melanoma cells
- Melanoma A375 cells treated with the BRAFV600E inhibitor vemurafenib
Most Relevant Literature
- Assessing the Therapeutic Impacts of HAMLET and FOLFOX on BRAF-Mutated Colorectal Cancer: A Study of…
- A comprehensive overview of the molecular features and therapeutic targets in BRAFV600E-mutant color…
- Does BRAF V600E mutation affect recurrence rate of ameloblastomas? Systematic review and meta-analys…
- Hairy cell leukaemia with an IGH-BRAF fusion gene.
- BRAF variant allele fraction-A predictor of response to targeted therapy?
Most Relevant Clinical Trials
- Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations
- Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Dis…
- Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon…
- HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma
- GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma
